Search Results
Slidesets
Debate: Clinical Value of Proviral DNA Resistance Testing - PRO | Francesca Ceccherini-Silberstein
Presented at:
European Meeting on HIV & Hepatitis 2024
Slidesets
A Cardiac Risk Algorithm to Predict the Probability of Drug-Induced Torsades de Pointes with Novel Anti-TB Agents- Alexander Berg, PharmD, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
AB 07 Sub-Maximal 2-day Cardiopulmonary Exercise Testing_Callum Thomas
Presented at:
Demystifying Long COVID International Conference 2024
E-Posters
Operational Cost per Test of Cryptococcal Antigen (CrAg) Reflexed Testing in South Africa in the Light of Proposed Inclusion of Samples With a CD4 Count Between 100-200cells/µL
M. Coetzee
Presented at:
INTEREST 2020
Slidesets
Pharmacokinetics of Dolutegravir after Switching to Abacavir/Dolutegravir/Lamivudine from an Efavirenz Based Regimen: A PK Substudy from Striiving - Dr. Jeff de Wet
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Post Vaccination Antibody Testing: Its Role for Determining Level | Benjamin Larimer, PhD
Presented at:
COVID-19 Vaccine Development & Implementation Workshop 2021 - February Edition
Slidesets
Debate: Clinical Value of Proviral DNA Resistance Testing - CON | Anne-Geneviève Marcelin
Presented at:
European Meeting on HIV & Hepatitis 2024
Videos
Challenges and Dynamics of Identifying, Testing and Linking to Care (...) - Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2024
Abstracts
Genedrive® Point of Care Qualitative Testing in a Pilot Hepatitis C Treatment Program
V. Hechter
Presented at:
Conference on Liver Disease in Africa (COLDA) 2021
Abstracts
Impact of COVID-19 on HIV testing and care at a university hospital in Taiwan
P. Wu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2021
Presented at:
APACC 2021